Suppliers / J.B. Chemicals & Pharmaceuticals

J.B. Chemicals & Pharmaceuticals

India Updated 9 July 2026

J.B. Chemicals & Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 97 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), EDA (EG) and JFDA (JO). Its GMP standing is certified by CDSCO (India), NAFDAC (NG) and EDA (EG), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 7 March 2025 as NAI. Customs aggregates show $165.6M of exports covering 6,246 molecules to 64 destinations in 2025.

0
active US DMFs
0
valid CEPs
11
registered plants 2 with an FDA FEI number
97
filings across 10 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 7 March 2025 NAI US FDA
  • 23 October 2022 VAI US FDA
  • 7 February 2020 VAI US FDA
  • 8 December 2018 VAI US FDA
  • 24 August 2018 VAI US FDA
  • 24 June 2016 NAI US FDA
  • 18 October 2013 VAI US FDA
  • 2 December 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Panoli, India Not on file
panoli 394 116bharuch, India Not on file
vapi 396 195valsad, India Not on file
Plot No., India Not on file
dustrial area ankleshwar 393 002 bharuch, India Not on file
vapivapi 396 195valsad, India Not on file

5 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 52 None
EDA (EG) 17 1
JFDA (JO) 7 None
DIGEMAPS (DO) 6 None
PPB (KE) 4 None
EFDA (ET) 4 None
CDSCO (India) None 11
NAFDAC (NG) None 2
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $10.5M 28
2025 Not reported $165.6M 64
2024 Not reported $150.3M 62
2023 Not reported $165.9M 68

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. J.B. Chemicals & Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 7 March 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts